These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

550 related items for PubMed ID: 2150631

  • 1. Long-term treatment with the combination ethinylestradiol and cyproterone acetate in polycystic ovary syndrome.
    Falsetti L, Galbignani E.
    Contraception; 1990 Dec; 42(6):611-9. PubMed ID: 2150631
    [Abstract] [Full Text] [Related]

  • 2. Effects of long-term administration of an oral contraceptive containing ethinylestradiol and cyproterone acetate on lipid metabolism in women with polycystic ovary syndrome.
    Falsetti L, Pasinetti E.
    Acta Obstet Gynecol Scand; 1995 Jan; 74(1):56-60. PubMed ID: 7856434
    [Abstract] [Full Text] [Related]

  • 3. A new association of ethinylestradiol (0.035 mg) cyproterone acetate (2 mg) in the therapy of polycystic ovary syndrome.
    Falsetti L, Dordoni D, Gastaldi C, Gastaldi A.
    Acta Eur Fertil; 1986 Jan; 17(1):19-25. PubMed ID: 2941960
    [Abstract] [Full Text] [Related]

  • 4. Effects of a low-dose estrogen-antiandrogen combination (Diane-35) on clinical signs of androgenization, hormone profile and ovarian size in patients with polycystic ovary syndrome.
    Prelević GM, Würzburger MI, Balint-Perić L, Puzigaća Z.
    Gynecol Endocrinol; 1989 Dec; 3(4):269-80. PubMed ID: 2516704
    [Abstract] [Full Text] [Related]

  • 5. The influence of combined cyproterone acetate-ethinyl oestradiol therapy on serum levels of dehydroepiandrosterone, androstenedione, and testosterone in hirsute women.
    Frölich M, Lachinsky N, Moolenaar AJ.
    Acta Endocrinol (Copenh); 1977 Feb; 84(2):333-42. PubMed ID: 138326
    [Abstract] [Full Text] [Related]

  • 6. The effect of monophasic combinations of ethinyl estradiol and norethindrone on gonadotropins, androgens and sex hormone binding globulin: a randomized trial.
    Moutos D, Smith S, Zacur H.
    Contraception; 1995 Aug; 52(2):105-9. PubMed ID: 8536446
    [Abstract] [Full Text] [Related]

  • 7. Long-term treatment of hirsutism: desogestrel compared with cyproterone acetate in oral contraceptives.
    Porcile A, Gallardo E.
    Fertil Steril; 1991 May; 55(5):877-81. PubMed ID: 1827074
    [Abstract] [Full Text] [Related]

  • 8. Effect of a combination of ethinylestradiol and desogestrel in adolescents with oligomenorrhea and ovarian hyperandrogenism.
    Nappi C, Farace MJ, Leone F, Minutolo M, Tommaselli AP, Montemagno U.
    Eur J Obstet Gynecol Reprod Biol; 1987 Jul; 25(3):209-19. PubMed ID: 2956138
    [Abstract] [Full Text] [Related]

  • 9. A comparative randomized trial on the impact of two low-dose oral contraceptives on ovarian activity, cervical permeability, and endometrial receptivity.
    Rossmanith WG, Steffens D, Schramm G.
    Contraception; 1997 Jul; 56(1):23-30. PubMed ID: 9306028
    [Abstract] [Full Text] [Related]

  • 10. Androgen dependence of hirsutism, acne, and alopecia in women: retrospective analysis of 228 patients investigated for hyperandrogenism.
    Karrer-Voegeli S, Rey F, Reymond MJ, Meuwly JY, Gaillard RC, Gomez F.
    Medicine (Baltimore); 2009 Jan; 88(1):32-45. PubMed ID: 19352298
    [Abstract] [Full Text] [Related]

  • 11. An open study of Triphasil and Diane 50 in the treatment of acne.
    Wishart JM.
    Australas J Dermatol; 1991 Jan; 32(1):51-4. PubMed ID: 1834045
    [Abstract] [Full Text] [Related]

  • 12. Daily serum follicle-stimulating hormone, luteinizing hormone, and plasma testosterone and androstenedione in hirsute women with polycystic sclerotic ovaries: effects of diethylstilbestrol and norethindrone acetats.
    Daane TA, Dignam WJ, Frankland MV, Simmer HH, Parlow AF.
    Am J Obstet Gynecol; 1973 Oct 01; 117(3):392-9. PubMed ID: 4729733
    [Abstract] [Full Text] [Related]

  • 13. Serum levels of FSH, LH, estradiol-17 beta and progesterone following the administration of a combined oral contraceptive containing 20 micrograms ethinylestradiol.
    Carlström K, Lunell NO, Zador G.
    Gynecol Obstet Invest; 1978 Oct 01; 9(6):304-11. PubMed ID: 754992
    [Abstract] [Full Text] [Related]

  • 14. New natural oestradiol/cyproterone acetate oral contraceptive for pre-menopausal women.
    Hirvonen E, Stenman UH, Mälkönen M, Rasi V, Vartiainen E, Ylöstalo P.
    Maturitas; 1988 Oct 01; 10(3):201-13. PubMed ID: 2972897
    [Abstract] [Full Text] [Related]

  • 15. Pharmacodynamic studies on desogestrel administered alone and in combination with ethinylestradiol.
    Cullberg G.
    Acta Obstet Gynecol Scand Suppl; 1985 Oct 01; 133():1-30. PubMed ID: 3161265
    [Abstract] [Full Text] [Related]

  • 16. Effects of cyproterone acetate plus ethinylestradiol low dose on plasma androgens and lipids in mildly hirsute or acneic young women.
    Vermeulen A, Rubens R.
    Contraception; 1988 Oct 01; 38(4):419-28. PubMed ID: 2974791
    [Abstract] [Full Text] [Related]

  • 17. Effect of two oral contraceptives containing ethinylestradiol and gestodene or norgestimate upon androgen parameters and serum binding proteins.
    Wiegratz I, Jung-Hoffmann C, Kuhl H.
    Contraception; 1995 Jun 01; 51(6):341-6. PubMed ID: 7554973
    [Abstract] [Full Text] [Related]

  • 18. A randomized cross-over study on various hormonal parameters of two triphasic oral contraceptives.
    Aden U, Jung-Hoffmann C, Kuhl H.
    Contraception; 1998 Aug 01; 58(2):75-81. PubMed ID: 9773261
    [Abstract] [Full Text] [Related]

  • 19. Attenuation of mild hyperandrogenic activity in postpubertal acne by a triphasic oral contraceptive containing low doses of ethynyl estradiol and d,l-norgestrel.
    Lemay A, Dewailly SD, Grenier R, Huard J.
    J Clin Endocrinol Metab; 1990 Jul 01; 71(1):8-14. PubMed ID: 2142494
    [Abstract] [Full Text] [Related]

  • 20. [Clinical use of antiandrogens in the female].
    Moltz L, Schwartz U, Hammerstein J.
    Gynakologe; 1980 Mar 01; 13(1):1-17. PubMed ID: 6299908
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.